Medicine belongs to the pharmaceutical industry and is an important part of China's national economy. It is an industry that combines traditional industries with modern industries and integrates primary, secondary and tertiary industries. Its main categories include: chemical raw materials and preparations, Chinese herbal medicines, Chinese herbal pieces, Chinese patent medicines, antibiotics, biological products, biochemical drugs, radioactive drugs, medical devices, sanitary materials, pharmaceutical machinery, packaging materials and pharmaceutical business. The pharmaceutical industry has carried out the policy of "developing medicine through science and education" and increased the research and development of new products. The output value rate of new products reached 15.8% in 1999. During the Ninth Five-Year Plan period, pharmaceutical enterprises and scientific research units in China * * * obtained 5043 certificates of various new drugs, involving 2 1 12 varieties, including 108 national first-class new drug certificates.
Legal basis:
People's Republic of China (PRC) Drug Administration Law
Article 2 This Law shall apply to the research, production, trading, use, supervision and administration of drugs within the territory of People's Republic of China (PRC).
Drugs mentioned in this Law refer to substances used for preventing, treating and diagnosing human diseases, purposefully regulating human physiological functions, and specifying indications or functional indications, usage and dosage, including traditional Chinese medicines, chemicals and biological products.
Article 3 Drug management should focus on people's health, adhere to the principles of risk management, whole-process control and social governance, establish a scientific and strict supervision and management system, comprehensively improve drug quality, and ensure drug safety, effectiveness and accessibility.